<DOC>
	<DOCNO>NCT02919618</DOCNO>
	<brief_summary>Phase I/II Study EP-guided Noninvasive Cardiac Radioablation ( ENCORE ) Treatment Ventricular Tachycardia</brief_summary>
	<brief_title>Phase I/II Study EP-guided Noninvasive Cardiac Radioablation Treatment Ventricular Tachycardia</brief_title>
	<detailed_description>Patients Ventricular Tachycardia ( VT ) fail standard therapy ( medicine , invasive catheter ablation ) limit option , one-year survival 20 % . Preclinical data demonstrate single fraction stereotactic body radiotherapy ( SBRT ) discrete portion heart feasible may result reduction elimination VT . The efficacy may improve guided cardiac electrophysiologic ( EP ) test . In total , map ablation propose EP-guided Noninvasive Cardiac Radioablation ( ENCORE ) rapid totally non-invasive method . Overall safety early efficacy ENCORE rigorously study prospective trial to-date . The purpose phase I/II study demonstrate short-term safety preliminary efficacy ENCORE patient life-threatening , treatment-refractory VT .</detailed_description>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Tachycardia , Ventricular</mesh_term>
	<mesh_term>Ventricular Premature Complexes</mesh_term>
	<criteria>1 . DOCUMENTED VT : 1 . Patient must document sustained monomorphic ventricular tachycardia document either 12lead ECG intracardiac ICD interrogation — OR— 2 . Monomorphic PVCs document 12lead ECG . 2 . ANTIARRHYTHMIC MEDICATION : Patient must fail become intolerant least one antiarrhythmic medication ( amiodarone , sotalol , mexiletine ) . AND— 3 . CATHETER ABLATION : Patient must fail least one invasive catheter ablation procedure , contraindication catheter ablation procedure ( e.g. , LV thrombus , severe pulmonary disease ) , VT think arise protect location ( e.g. , epicardial VT history previous cardiac surgery ) . 4 . MINIMUM VT BURDEN : Patient must either : 1 . At least 3 VT episode ( sustain VT , ICD ATP ICD shock ) previous 6 month prior enrollment OR— 2 . &gt; 20 % PVC burden cardiomyopathy ( LVEF &lt; 50 % ) 5 . Patient must deem medically fit stereotactic body radiation therapy treat physician . 6 . Patient must &gt; 18 year old . 7 . Patient must able understand willing sign IRB approve write informed consent document . 1 . Patient must past history radiotherapy within project treatment field . 2 . Advanced symptomatic heart failure define NYHA Class IV heart failure ( inotrope dependent and/or current leftventricular assist device ( LVAD ) ) 3 . Polymorphic VT ventricular fibrillation ( VF ) clinical heart rhythm ( determined 12lead ECG and/or ICD interrogation ) . 4 . More 3 distinct clinical VT morphology observe ( ECG ICD interrogation invasive EP study ) OR 5 distinct induce VT morphology ECGI test . 5 . Advanced myocardial scar substrate would require stereotactic delivery target volume deem unsafe treat physician . 6 . Unlikely live 12 month , absence VT , best base clinical judgment treat enrol physician . 7 . Patient must pregnant and/or breastfeeding must negative pregnancy test within 14 day study entry .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Ventricular Tachycardia</keyword>
	<keyword>Ablation</keyword>
	<keyword>Noninvasive</keyword>
</DOC>